Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by aBullishTraderon Jan 15, 2018 9:44am

74 Views

Post# 27357925

RE:BOUNCE UPWARDS??? TOLD YOU !!!!

CarbonBigFoot , you were right all along in this board ! I am glad that you are a long term investor in this stock, and I am glad I listened to your advices. Sure I may be at a small loss at the moment, avreage at 0.28, but not to worry, because the potential in this industry and company is enormous, just like you said !! Great Job !!! Holding !!!

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property